Global Pharmaceutical Grade Cannabis Market Growth 2025-2031

The global Pharmaceutical Grade Cannabis market size is predicted to grow from US$ 990 million in 2025 to US$ 1526 million in 2031; it is expected to grow at a CAGR of 7.5% from 2025 to 2031.

"Pharmaceutical grade cannabis" is a term used to describe cannabis products that meet the high-quality and safety standards required for pharmaceutical use. This designation implies that the cannabis has been cultivated, processed, and tested in a manner consistent with pharmaceutical regulations and guidelines.

Legalization and Regulation: Many countries and states were moving towards the legalization and regulation of medical cannabis. This trend was expected to continue, opening up new markets for pharmaceutical-grade cannabis products.

Clinical Trials: Pharmaceutical companies and research institutions were conducting clinical trials to evaluate the safety and efficacy of cannabis-based medications for various medical conditions, including chronic pain, epilepsy, multiple sclerosis, and more.

Product Diversification: The market was witnessing the development of a wide range of pharmaceutical-grade cannabis products, including capsules, tinctures, transdermal patches, and inhalers. These products were designed to provide consistent dosing and delivery methods.

Quality Control: As the pharmaceutical-grade cannabis market matured, there was a greater emphasis on quality control and standardization of production processes. Ensuring product consistency and purity was a top priority.

International Expansion: Companies were exploring opportunities to expand into international markets as more countries considered legalizing medical cannabis. Exporting pharmaceutical-grade cannabis products to countries with established medical cannabis programs became a strategic focus for some companies.

LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Grade Cannabis Industry Forecast” looks at past sales and reviews total world Pharmaceutical Grade Cannabis sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade Cannabis sales for 2025 through 2031. With Pharmaceutical Grade Cannabis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade Cannabis industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade Cannabis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade Cannabis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Grade Cannabis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade Cannabis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade Cannabis.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade Cannabis market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Dronabinol
Nabilone
Nabiximols
Cannabidiol
Others

Segmentation by Application:
Oral Medications
Topical Medications

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Ultra Health
Mammoth Farms
Palo Verde Center
Hexo Corp
Bright Green Corporation
Copperstate Farms
Los Suenos Farms
Canna
Village Farms
Aurora
Canopy Growth
Cresco Labs
Glass House Farms
Organigram
C3 International
CannTrust
FlowerOne
Solaris Farms
7Acres
ThePharm

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharmaceutical Grade Cannabis market?

What factors are driving Pharmaceutical Grade Cannabis market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pharmaceutical Grade Cannabis market opportunities vary by end market size?

How does Pharmaceutical Grade Cannabis break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.